Liquid Dosage

In addition, GEA offers plant for the formulation of syrups, suspensions, parenterals and blood plasma fractionation. Systems for the production, storage, and distribution of clean utilities and media complete the portfolio.
With a proven track record in processes such as preformulation and API production, including fermentation, clarification, membrane filtration and separation, homogenization and micronization, crystallization, classification, concentration, lyophilization and fractionation, as well as complete integration with upstream and downstream processes, GEA’s standalone machines or package units guarantee a high yield of valuable substances and operate efficiently, reliably and economically throughout a long service life.
Our equipment portfolio includes a comprehensive range of standard and customized vessels, bioreactors, fermenters and flow components, as well as advanced processing modules for the dairy, food and juice industries.
Whether you produce infusion solutions, electrolytes, anesthetics, oncology drugs, inhalables, monoclonal antibodies (mAbs), vaccines or therapeutic proteins, or whether you’re a manufacturer of serums, injection solutions, insulin or drop solutions, our wide range of modular plant and equipment performs any task and takes account of any specific requirements or conditions.
16 の 4 を表示する

GEA の革新的な CIP コンセプトは、包括的な最高規格を満たしています。当社のエキスパートは、プロセスのあらゆる時点で、製品の安全性を保証しています。どのアップグレードも、現場の個々の条件および顧客の要件に適合し、顕著な節約を実現します。

GEA Hilgeでは、飲料、食品、製薬産業における多岐にわたる感度の高い用途に汎用性の高い遠心ポンプおよび容積型ポンプをご用意しております。

GEA's thorough understanding of the lyophilization process enables them to supply a comprehensive range of products and services, comprising laboratory equipment, pilot plants for research and small-scale production batches, industrial size pharmaceutical production freeze dryers.

GEA's versatile range of R&D drying & particle processing equipment - for advanced powder processing within food and dairy products, chemicals and pharmaceuticals.
Whether it’s a fad or the future, 100% vial traceability is becoming an increasingly important consideration in the pharmaceutical freeze drying industry. Keeping a close eye on developments is GEA. We’re investigating possible solutions and, what’s more, we have the experience, expertise and know-how to implement them.
At GEA, our commitment to engineering for a better world fuels our pursuit of innovative solutions that enhance patient care and safety. One of our most promising ventures in recent years is aseptic spray drying – a technology that promises to revolutionize pharmaceutical manufacturing.